Viewing Study NCT03246685

Bugs

Ignite Creation Date: 2025-12-18 @ 8:36 AM

Ignite Modification Date: 2025-12-23 @ 9:49 PM

Study NCT ID: NCT03246685

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module